Key Trends in the In Vitro Diagnostic Market 2023: Multiplex Testing is Proliferating

News provided by

Nov 17, 2023, 06:59 ET

DUBLIN, Nov. 17, 2023 /PRNewswire/ -- The "In Vitro Diagnostic (IVD) Trends and Market Update: 2023" report has been added to ResearchAndMarkets.com's offering.

In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets, and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient.

This report is the most up-to-date resource on these and other key market trends. Diagnostic test products have never been more important.

There are some growing segments in the market that have attracted industry attention. Among these are Point-of-Care, next-generation sequencing (NGS), cancer testing, and companion diagnostics technologies. Immunochemistry, mass spectrometry. Gene testing and molecular diagnostics are also segments of great market interest, anticipated to be a big part of the future of IVD.

Trends highlighted throughout Q3 2023 include:

Multiplex testing is proliferating
Continued interest in adopting AI technologies

In IVD Trends and Market Update:

What's Driving Growth in the IVD Market in Q3 and the last half of 2023?
What Major Trends are Affecting the Market in Q3 and the last half of 2023?
How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2023?
What Product Trends and New Developments Will Shape the IVD Market in the last half of 2023?

Key Topics Covered:

Chapter 1: Worldwide IVD Market - October 2023 Update

IVD Market Demand and Growth
Effect of COVID-19 on Market Segments

Chapter 2: Product Trends and New Developments

Selected New - Q3 2023 - Core IVD Product Launches, Developments and Trends
Clinical Chemistry
Flow Cytometry
Immunoassay
Mass Spectrometry
Molecular
Personalized Medicine
POC
Sequencing
Selected COVID-19 Developments - Q3 2023
Antigen/Antibody
Molecular

Chapter 3: Top IVD Market Participant Results

Selected Competitive Leader Updates
Abbott Laboratories
Becton Dickinson and Co
bioMerieux SA
Danaher Corporation
Hologic, Inc.
QuidelOrtho Corporation
Roche Diagnostic
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific

Chapter 4: New Opportunities

Multiplex Testing
Next-Generation Sequencing
Artificial Intelligence Future Trends
Disruptive Technologies

For more information about this report visit https://www.researchandmarkets.com/r/8rntfm

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets